Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Research Report 2019

Table of Contents

Executive Summary

1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Overview

• 1.1 Product Overview and Scope of T Cell Surface Glycoprotein CD3 Epsilon Chain
• 1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Type
  • 1.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 ND-007
  • 1.2.3 Foralumab
  • 1.2.4 Coltelizumab
  • 1.2.5 AVA-002
  • 1.2.6 Others
• 1.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Segment by Application
  • 1.3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Comparison by Application (2014-2025)
  • 1.3.2 Autoimmune Disorders
  • 1.3.3 Hepatitis B
  • 1.3.4 Multiple Sclerosis
  • 1.3.5 Prostate Cancer
  • 1.3.6 Others
• 1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market by Region
  • 1.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size
  • 1.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (2014-2025)
  • 1.4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2025)

2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Competition by Manufacturers

• 2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Manufacturers (2014-2019)
• 2.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Share by Manufacturers (2014-2019)
• 2.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites, Area Served, Product Types
• 2.5 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Competitive Situation and Trends
  • 2.5.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Rate
  • 2.5.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Regions

• 3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Regions
• 3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Regions (2014-2019)
• 3.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production
  • 3.4.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
  • 3.4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production
  • 3.5.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
  • 3.5.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2019)
  • 3.6.1 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
  • 3.6.2 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production (2014-2019)
  • 3.7.1 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate (2014-2019)
  • 3.7.2 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)

4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption by Regions

• 4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption by Regions
• 4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
• 4.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
• 4.4 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)
• 4.5 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption (2014-2019)

5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price Trend by Type

• 5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Market Share by Type (2014-2019)
• 5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2014-2019)
• 5.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price by Type (2014-2019)
• 5.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth by Type (2014-2019)

6 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Analysis by Applications

• 6.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Market Share by Application (2014-2019)
• 6.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in T Cell Surface Glycoprotein CD3 Epsilon Chain Business

• 7.1 Amgen Inc
  • 7.1.1 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.1.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Celgene Corp
  • 7.2.1 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 F. Hoffmann-La Roche Ltd
  • 7.3.1 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.3.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 GlaxoSmithKline Plc
  • 7.4.1 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.4.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 MacroGenics Inc
  • 7.5.1 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.5.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Meridigen Biotech Co Ltd
  • 7.6.1 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.6.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Numab Innovation AG
  • 7.7.1 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.7.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 SYNIMMUNE GmbH
  • 7.8.1 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.8.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Tiziana Life Sciences Plc
  • 7.9.1 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production Sites and Area Served
  • 7.9.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Product Introduction, Application and Specification
  • 7.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served

8 T Cell Surface Glycoprotein CD3 Epsilon Chain Manufacturing Cost Analysis

• 8.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of T Cell Surface Glycoprotein CD3 Epsilon Chain
• 8.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Distributors List
• 9.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Forecast

• 11.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast
  • 11.1.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Price and Trend Forecast (2019-2025)
• 11.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production Forecast by Regions (2019-2025)
  • 11.2.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
  • 11.2.3 China T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue Forecast (2019-2025)
• 11.3 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
  • 11.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
  • 11.3.3 China T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
  • 11.3.4 Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast (2019-2025)
• 11.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List